These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18843462)

  • 1. Effect of simvastatin on steroid-induced osteonecrosis evidenced by the serum lipid level and hepatic cytochrome P4503A in a rabbit model.
    Iwakiri K; Oda Y; Kaneshiro Y; Iwaki H; Masada T; Kobayashi A; Asada A; Takaoka K
    J Orthop Sci; 2008 Sep; 13(5):463-8. PubMed ID: 18843462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model.
    Masada T; Iwakiri K; Oda Y; Kaneshiro Y; Iwaki H; Ohashi H; Takaoka K
    J Orthop Res; 2008 Jan; 26(1):91-5. PubMed ID: 17787012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of steroid-metabolizing hepatic enzyme (cytochrome P450 3A) activity may elevate responsiveness to steroids and may increase risk of steroid-induced osteonecrosis even with low glucocorticoid dose.
    Tokuhara Y; Wakitani S; Oda Y; Kaneshiro Y; Masada T; Kim M; Kadoya Y; Azuma T; Takaoka K
    J Orthop Sci; 2009 Nov; 14(6):794-800. PubMed ID: 19997828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits.
    Motomura G; Yamamoto T; Miyanishi K; Jingushi S; Iwamoto Y
    Arthritis Rheum; 2004 Oct; 50(10):3387-91. PubMed ID: 15476219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits.
    Motomura G; Yamamoto T; Miyanishi K; Kondo K; Hirota Y; Iwamoto Y
    J Rheumatol; 2008 Dec; 35(12):2391-4. PubMed ID: 19004034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P4503A activity affects the gender difference in the development of steroid-induced osteonecrosis in rabbits.
    Ikemura S; Yamamoto T; Motomura G; Yamaguchi R; Zhao G; Iwasaki K; Iwamoto Y
    Int J Exp Pathol; 2014 Apr; 95(2):147-52. PubMed ID: 24673874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edaravone, a novel free radical scavenger, prevents steroid-induced osteonecrosis in rabbits.
    Li GY; Feng Y; Cheng TS; Yin JM; Zhang CQ
    Rheumatology (Oxford); 2013 Mar; 52(3):438-47. PubMed ID: 23173187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARĪ³ expression and activating Wnt signaling pathway.
    Jiang Y; Zhang Y; Zhang H; Zhu B; Li P; Lu C; Xu Y; Chen W; Lin N
    Exp Biol Med (Maywood); 2014 Mar; 239(3):347-55. PubMed ID: 24510055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new compound-specific pleiotropic effect of statins: modification of plasma gamma-tocopherol levels.
    Werba JP; Cavalca V; Veglia F; Massironi P; De Franceschi M; Zingaro L; Tremoli E
    Atherosclerosis; 2007 Jul; 193(1):229-33. PubMed ID: 16860808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis.
    Kaneshiro Y; Oda Y; Iwakiri K; Masada T; Iwaki H; Hirota Y; Kondo K; Takaoka K
    Clin Pharmacol Ther; 2006 Oct; 80(4):396-402. PubMed ID: 17015057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study.
    Nishida K; Yamamoto T; Motomura G; Jingushi S; Iwamoto Y
    Clin Orthop Relat Res; 2008 May; 466(5):1054-8. PubMed ID: 18350345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoic acid prevents steroid-induced osteonecrosis in rabbits.
    Lu BB; Li KH
    Rheumatol Int; 2012 Jun; 32(6):1679-83. PubMed ID: 21431293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of an anti-platelet drug on the prevention of steroid-induced osteonecrosis in rabbits.
    Yamaguchi R; Yamamoto T; Motomura G; Ikemura S; Iwasaki K; Zhao G; Iwamoto Y
    Rheumatology (Oxford); 2012 May; 51(5):789-93. PubMed ID: 21742723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Animal models for steroid-induced osteonecrosis].
    Yamamoto T; Miyanishi K; Motomura G; Nishida K; Iwamoto Y; Sueishi K
    Clin Calcium; 2007 Jun; 17(6):879-86. PubMed ID: 17548927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats.
    Nozaki Y; Kumagai K; Miyata N; Niwa M
    Acta Orthop; 2012 Feb; 83(1):87-92. PubMed ID: 22313369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction in streptozotocin-diabetic rats is not reversed by dietary probucol or simvastatin supplementation.
    Palmer AM; Gopaul N; Dhir S; Thomas CR; Poston L; Tribe RM
    Diabetologia; 1998 Feb; 41(2):157-64. PubMed ID: 9498648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset of steroid-induced osteonecrosis in rabbits and its relationship to hyperlipaemia and increased free fatty acids.
    Kabata T; Kubo T; Matsumoto T; Hirata T; Fujioka M; Takahashi KA; Yagishita S; Kobayashi M; Tomita K
    Rheumatology (Oxford); 2005 Oct; 44(10):1233-7. PubMed ID: 15972352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis.
    Ichiseki T; Kaneuji A; Katsuda S; Ueda Y; Sugimori T; Matsumoto T
    Rheumatology (Oxford); 2005 Apr; 44(4):456-60. PubMed ID: 15598705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypolipidemic effect of NK-104 and other 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in guinea pigs.
    Suzuki H; Yamazaki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
    Arzneimittelforschung; 2001 Jan; 51(1):38-45. PubMed ID: 11215324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.